Grade My Investments
HomeFree Stock Grades › QTRX

Quanterix Corporation (QTRX) Stock Grade

QTRX · Healthcare

B-
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$271.2M
P/E Ratio
Revenue Growth (YoY)
+2.4%
Net Margin
-77.3%
Return on Equity
Dividend Yield
None

About Quanterix Corporation's fundamentals

Quanterix Corporation is a medical device company with a market capitalization of $271.2 million that reported modest revenue growth of 2.4% year-over-year, but the company is currently unprofitable with a net margin of -77.3% and reported a net loss in its latest annual statement. The company does not pay a dividend. With such significant losses relative to its revenue base, Quanterix is in a development or scaling phase where expenses substantially exceed current income generation.

Track QTRX free — no credit card required. Live grade + monthly AI report →